Does an Arthritis Drug Help Patients Battling Severe COVID? It Depends on the Study
WEDNESDAY, March 3, 2021 (HealthDay News) -- Two new studies suggest that the jury is still out on whether the arthritis drug tocilizumab helps those with severe COVID-19.
Both reports were published recently in the New England Journal of Medicine. The first, from scientists at the University of California, San Diego, found tocilizumab didn't improve outcomes or reduce the risk of death in patients with severe COVID-19 pneumonia. However, it might shorten hospital stays and the length of time these patients spend on ventilators.Full Article